Comparative laboratory effectiveness of low molecular weight heparins in patients with acute coronary syndrome and no ST segment elevation
Aim. To compare anti-Xa plasma activity levels in patients with acute coronary syndrome (ACS) and no ST segment elevation (non-STE ACS), receiving enoxaparin, nadroparin, or dalteparin. Material and methods. In total, 90 patients with non-STE ACS were divided into three groups (n=30 in each group),...
Saved in:
| Main Authors: | R. M. Linchak, V. S. Popov, K. F. Kim |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2011-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1462 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEVELOPMENT, VALIDATION AND APPLICATION OF ANTI-Xa- AND ANTI-IIa-ENOXAPARINE SODIUM ASSAY
by: B. Yu. Margaeva, et al.
Published: (2019-01-01) -
Establishment and validation of a method for determining anti-Xa factor potency of enoxaparin sodium
by: En Zhang, et al.
Published: (2025-05-01) -
UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME
by: O. V. Krikunova, et al.
Published: (2018-03-01) -
POSSIBILITIES OF USING LOW-MOLECULAR-WEIGHT HEPARIN IN THE COMPLEX TREATMENT OF WOMEN WITH TUMORS OF THE REPRODUCTIVE SYSTEM
by: A. G. Kedrova, et al.
Published: (2017-06-01) -
PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION
by: A. V. Syrov, et al.
Published: (2010-04-01)